These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1101331)

  • 1. [Niflumic acid].
    Danysz A
    Reumatologia; 1975; 13(3):227-32. PubMed ID: 1101331
    [No Abstract]   [Full Text] [Related]  

  • 2. Examinations with Donalgin in locomotor diseases treated at the out-patient department.
    Kovács E
    Ther Hung; 1977; 25(2):75-8. PubMed ID: 302503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Controlled clinical study on the use of morniflumate in the treatment of inflammatory-degenerative diseases of the locomotor system].
    Raffaetà G; Saponati G; Terzuoli A
    G Clin Med; 1987 Oct; 68(10):507-13. PubMed ID: 3428515
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical effectivity of Donalgin--niflumic acid--in locomotor diseases.
    Krakovits G; Tallián A; Képes P
    Ther Hung; 1981; 29(2):77-85. PubMed ID: 6765143
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of the preparation Donalgin in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Sadkiewicz S; Barwik-Schramm A; Grzywa M; Letkiewicz C; Piotrowska E; Procel Z; Reszkowska H; Wippel A; Woźniak M; Zmudzińska I
    Reumatologia; 1982; 20(1-2):75-80. PubMed ID: 6761815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical assay of niflumic acid in rheumatology].
    Gougeon J; Moreau-Hottin J; Bajolet S; Etienne JC
    Therapie; 1968; 23(4):951-60. PubMed ID: 5744599
    [No Abstract]   [Full Text] [Related]  

  • 7. [The beta-morpholino ethyl ester of niflumic acid in the treatment of orchi-epididymitis].
    Mazeman E; Biserte J
    Lille Med; 1980 Nov; 25(9):541-4. PubMed ID: 7453494
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of Donalgin on locomotor disease.
    Abrányi I; Papp I
    Ther Hung; 1977; 25(1):20-3. PubMed ID: 854866
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of an anti-inflammatory agent, well tolerated by children, in the O.R.L. surgery].
    Morgon AH; Dubreuil C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1978 Jun; 27(6):419-22. PubMed ID: 151729
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical investigation of analgesic and anti-inflammatory effects of niflumic acid following oral surgery].
    Todorović LJ; Petrović V; Kafedziska V
    Stomatol Glas Srb; 1982; 29(5):325-30. PubMed ID: 6964699
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastroprotective effects of morniflumate, an esterified anti-inflammatory drug.
    Schiantarelli P; Cadel S; Folco GC
    Arzneimittelforschung; 1984; 34(8):885-90. PubMed ID: 6333880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of a niflumic acid derivative in tonsil surgery in children - controlled study].
    Lacomme Y; Pessey JJ
    Rev Laryngol Otol Rhinol (Bord); 1978; 99(1-2):159-63. PubMed ID: 353942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary study of the therapeutic action and tolerance of niflumic acid in pediatric otorhinolaryngology].
    Traissac L; Roche JC
    Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):317-21. PubMed ID: 897412
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of niflumic acid on chronic rheumatoid arthritis].
    Shichikawa K; Onoda T
    Ryumachi; 1976 May; 16(2):199-211. PubMed ID: 785616
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative trial by double-blind method of a niflumic acid derivative and oxyphenbutazone in pediatric O. R. L].
    Traissac L; Roche JC
    Rev Laryngol Otol Rhinol (Bord); 1979; 100(1-2):151-61. PubMed ID: 379941
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental assessment of an anti-inflammatory agent].
    Marmo E; Matera A
    Arzneimittelforschung; 1973 Jun; 23(6):846-51. PubMed ID: 4125282
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of the beta-morpholinoethylester of niflumic acid in children's dentistry].
    Benoit P; Michelet FX; Benoit JP
    Rev Odontostomatol Midi Fr; 1975; (4):249-61. PubMed ID: 1236592
    [No Abstract]   [Full Text] [Related]  

  • 18. A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate).
    Schiantarelli P; Cadel S; Acerbi D
    Agents Actions; 1984 Feb; 14(2):247-56. PubMed ID: 6608862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative activities, tolerances and safety of nonsteroidal anti-inflammatory agents in rats.
    Wax J; Winder CV; Tessman DK; Stephens MD
    J Pharmacol Exp Ther; 1975 Jan; 192(1):172-8. PubMed ID: 1123722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trabeculoretraction and anti-inflammatory agents].
    Audoueineix E; Le Breton-Oliveau G; Chabanais JL
    Bull Soc Ophtalmol Fr; 1987 Apr; 87(4):541-3. PubMed ID: 3652371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.